disease that robs people of the ability to control their motor movements. No one knows exactly how many people are afflicted with MS. According to the National Institute of Neurological Disorders and Stroke, it is estimated that there are currently more than 350,000 people in the United States, who have been diagnosed with MS, where approximately 200 new cases are diagnosed each week. Current state-of-the-art therapies like the Israeli-invented Copaxone clearly help, but may not be enough, says Dr. Gozin, whose wide-ranging research has included work on classified projects for the U.S. Department of Defense.
"Multiple sclerosis is a very serious clinical condition," says Dr. Gozin. "I had a dream, an idea for a new kind of drug." He took this idea to MS expert Prof. Howard Weiner at Harvard University, and the two began a collaboration.
"I wanted to target with antioxidants specific receptors in the brain, which are involved in the disease progress, to stall the deterioration of motor function in MS sufferers," Dr. Gozin says. The US-Israeli researchers started from the belief that buckyballs, and brain-targeted moieties attached to them, may be able to achieve success in treating MS.
A Dose of C60
"We've created a molecule based on the C60 fullerene, a soccer-ball-shape, with great biomedical potential," says Dr. Gozin. The Tel Aviv University team, including graduate student Amnon Bar-Shir, was the first to synthesize and patent this application, which is "programmed" to target specific receptors in the brain. "We are presently working on the next generation of this type of molecules, containing less exotic and more natural building blocks," Dr. Gozin reports.
Page: 1 2 Related biology news :1
. Tiny buckyballs squeeze hydrogen like giant Jupiter2
. Manufactured Buckyballs dont harm microbes that clean the environment3
. Buckyballs have high potential to accumulate in living tissue4
. Nicotinic receptors may be important targets for treatment of multiple addictions5
. A new radiation therapy treatment developed for head and neck cancer patients6
. Restoring sight, advances in fertility treatments and better visibility for pilots at FIO7
. Gamma globulin effective in treating eye infections caused by adenoviruses8
. Presence of gene mutation helps guide thyroid cancer treatment9
. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment10
. New genetic research into nicotine addiction shows promise for personalized treatment11
. Doctors learn to control their own brains pain responses to better treat patients